AstraZeneca PLC (Sweden) Technical Analysis
| AZN Stock | SEK 1,834 19.50 1.07% |
As of the 14th of February 2026, AstraZeneca PLC shows the Risk Adjusted Performance of 0.1246, downside deviation of 1.2, and Mean Deviation of 1.05. AstraZeneca PLC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
AstraZeneca PLC Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AstraZeneca, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AstraZenecaAstraZeneca |
AstraZeneca PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AstraZeneca PLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AstraZeneca PLC.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in AstraZeneca PLC on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding AstraZeneca PLC or generate 0.0% return on investment in AstraZeneca PLC over 90 days. AstraZeneca PLC is related to or competes with Swedish Orphan, BioGaia AB, Getinge AB, CellaVision, BioArctic, Synsam AB, and Newbury Pharmaceuticals. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercializatio... More
AstraZeneca PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AstraZeneca PLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AstraZeneca PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.2 | |||
| Information Ratio | 0.0998 | |||
| Maximum Drawdown | 8.79 | |||
| Value At Risk | (1.66) | |||
| Potential Upside | 2.44 |
AstraZeneca PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AstraZeneca PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AstraZeneca PLC's standard deviation. In reality, there are many statistical measures that can use AstraZeneca PLC historical prices to predict the future AstraZeneca PLC's volatility.| Risk Adjusted Performance | 0.1246 | |||
| Jensen Alpha | 0.1812 | |||
| Total Risk Alpha | 0.0962 | |||
| Sortino Ratio | 0.1176 | |||
| Treynor Ratio | 0.5921 |
AstraZeneca PLC February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1246 | |||
| Market Risk Adjusted Performance | 0.6021 | |||
| Mean Deviation | 1.05 | |||
| Semi Deviation | 1.01 | |||
| Downside Deviation | 1.2 | |||
| Coefficient Of Variation | 670.88 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.02 | |||
| Information Ratio | 0.0998 | |||
| Jensen Alpha | 0.1812 | |||
| Total Risk Alpha | 0.0962 | |||
| Sortino Ratio | 0.1176 | |||
| Treynor Ratio | 0.5921 | |||
| Maximum Drawdown | 8.79 | |||
| Value At Risk | (1.66) | |||
| Potential Upside | 2.44 | |||
| Downside Variance | 1.45 | |||
| Semi Variance | 1.02 | |||
| Expected Short fall | (1.19) | |||
| Skewness | 0.6706 | |||
| Kurtosis | 2.2 |
AstraZeneca PLC Backtested Returns
Currently, AstraZeneca PLC is very steady. AstraZeneca PLC secures Sharpe Ratio (or Efficiency) of 0.0973, which signifies that the company had a 0.0973 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for AstraZeneca PLC, which you can use to evaluate the volatility of the firm. Please confirm AstraZeneca PLC's Downside Deviation of 1.2, mean deviation of 1.05, and Risk Adjusted Performance of 0.1246 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%. AstraZeneca PLC has a performance score of 7 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AstraZeneca PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding AstraZeneca PLC is expected to be smaller as well. AstraZeneca PLC right now shows a risk of 1.45%. Please confirm AstraZeneca PLC semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if AstraZeneca PLC will be following its price patterns.
Auto-correlation | 0.35 |
Below average predictability
AstraZeneca PLC has below average predictability. Overlapping area represents the amount of predictability between AstraZeneca PLC time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AstraZeneca PLC price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current AstraZeneca PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 2403.31 |
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
AstraZeneca PLC Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for AstraZeneca PLC across different markets.
About AstraZeneca PLC Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AstraZeneca PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AstraZeneca PLC price pattern first instead of the macroeconomic environment surrounding AstraZeneca PLC. By analyzing AstraZeneca PLC's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AstraZeneca PLC's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AstraZeneca PLC specific price patterns or momentum indicators. Please read more on our technical analysis page.
AstraZeneca PLC February 14, 2026 Technical Indicators
Most technical analysis of AstraZeneca help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca from various momentum indicators to cycle indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1246 | |||
| Market Risk Adjusted Performance | 0.6021 | |||
| Mean Deviation | 1.05 | |||
| Semi Deviation | 1.01 | |||
| Downside Deviation | 1.2 | |||
| Coefficient Of Variation | 670.88 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.02 | |||
| Information Ratio | 0.0998 | |||
| Jensen Alpha | 0.1812 | |||
| Total Risk Alpha | 0.0962 | |||
| Sortino Ratio | 0.1176 | |||
| Treynor Ratio | 0.5921 | |||
| Maximum Drawdown | 8.79 | |||
| Value At Risk | (1.66) | |||
| Potential Upside | 2.44 | |||
| Downside Variance | 1.45 | |||
| Semi Variance | 1.02 | |||
| Expected Short fall | (1.19) | |||
| Skewness | 0.6706 | |||
| Kurtosis | 2.2 |
AstraZeneca PLC February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AstraZeneca stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 13,122 | ||
| Daily Balance Of Power | 0.45 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 1,826 | ||
| Day Typical Price | 1,829 | ||
| Price Action Indicator | 18.00 |
Additional Tools for AstraZeneca Stock Analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.